608 related articles for article (PubMed ID: 20419253)
1. Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
Liu R; Teo W; Tan S; Feng H; Padmanabhan P; Xing B
Analyst; 2010 May; 135(5):1031-6. PubMed ID: 20419253
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
3. A simple and specific assay for real-time colorimetric visualization of beta-lactamase activity by using gold nanoparticles.
Liu R; Liew R; Zhou J; Xing B
Angew Chem Int Ed Engl; 2007; 46(46):8799-803. PubMed ID: 17943938
[No Abstract] [Full Text] [Related]
4. Sensitive and selective detection of cysteine using gold nanoparticles as colorimetric probes.
Li L; Li B
Analyst; 2009 Jul; 134(7):1361-5. PubMed ID: 19562202
[TBL] [Abstract][Full Text] [Related]
5. Continuous colorimetric assay for acetylcholinesterase and inhibitor screening with gold nanoparticles.
Wang M; Gu X; Zhang G; Zhang D; Zhu D
Langmuir; 2009 Feb; 25(4):2504-7. PubMed ID: 19154124
[TBL] [Abstract][Full Text] [Related]
6. Engineered Amp C β-lactamase as a fluorescent screening tool for class C β-lactamase inhibitors.
Tsang MW; Chan PH; So PK; Ma DL; Tsang CW; Wong KY; Leung YC
Anal Chem; 2011 Mar; 83(6):1996-2004. PubMed ID: 21338058
[TBL] [Abstract][Full Text] [Related]
7. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
8. An operationally simple colorimetric assay of hyaluronidase activity using cationic gold nanoparticles.
Kim JW; Kim JH; Chung SJ; Chung BH
Analyst; 2009 Jul; 134(7):1291-3. PubMed ID: 19562190
[TBL] [Abstract][Full Text] [Related]
9. Colorimetric screening of bacterial enzyme activity and inhibition based on the aggregation of gold nanoparticles.
Jiang T; Liu R; Huang X; Feng H; Teo W; Xing B
Chem Commun (Camb); 2009 Apr; (15):1972-4. PubMed ID: 19333461
[TBL] [Abstract][Full Text] [Related]
10. β-cyclodextrin-functionalized silver nanoparticles for the naked eye detection of aromatic isomers.
Chen X; Parker SG; Zou G; Su W; Zhang Q
ACS Nano; 2010 Nov; 4(11):6387-94. PubMed ID: 20973513
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling of Henry-Michaelis and acyl-enzyme complexes between imipenem and Enterobacter cloacae P99 beta-lactamase.
Fenollar-Ferrer C; Donoso J; Frau J; Muñoz F
Chem Biodivers; 2005 May; 2(5):645-56. PubMed ID: 17192008
[TBL] [Abstract][Full Text] [Related]
12. Visual detection of melamine in infant formula at 0.1 ppm level based on silver nanoparticles.
Han C; Li H
Analyst; 2010 Mar; 135(3):583-8. PubMed ID: 20174714
[TBL] [Abstract][Full Text] [Related]
13. The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99.
Adediran SA; Zhang Z; Nukaga M; Palzkill T; Pratt RF
Biochemistry; 2005 May; 44(20):7543-52. PubMed ID: 15895997
[TBL] [Abstract][Full Text] [Related]
14. Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.
Crichlow GV; Kuzin AP; Nukaga M; Mayama K; Sawai T; Knox JR
Biochemistry; 1999 Aug; 38(32):10256-61. PubMed ID: 10441119
[TBL] [Abstract][Full Text] [Related]
15. Modifying the specificity and activity of the Enterobacter cloacae P99 beta-lactamase by mutagenesis within an M13 phage vector.
Siemers NO; Yelton DE; Bajorath J; Senter PD
Biochemistry; 1996 Feb; 35(7):2104-11. PubMed ID: 8652552
[TBL] [Abstract][Full Text] [Related]
16. Labeled gold nanoparticles immobilized at smooth metallic substrates: systematic investigation of surface plasmon resonance and surface-enhanced Raman scattering.
Driskell JD; Lipert RJ; Porter MD
J Phys Chem B; 2006 Sep; 110(35):17444-51. PubMed ID: 16942083
[TBL] [Abstract][Full Text] [Related]
17. Thermodynamic evaluation of a covalently bonded transition state analogue inhibitor: inhibition of beta-lactamases by phosphonates.
Nagarajan R; Pratt RF
Biochemistry; 2004 Aug; 43(30):9664-73. PubMed ID: 15274621
[TBL] [Abstract][Full Text] [Related]
18. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of beta-lactamases by monocyclic acyl phosph(on)ates.
Kaur K; Adediran SA; Lan MJ; Pratt RF
Biochemistry; 2003 Feb; 42(6):1529-36. PubMed ID: 12578365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
